These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36552790)

  • 1. Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer.
    Pardella E; Pranzini E; Nesi I; Parri M; Spatafora P; Torre E; Muccilli A; Castiglione F; Fambrini M; Sorbi F; Cirri P; Caselli A; Puhr M; Klocker H; Serni S; Raugei G; Magherini F; Taddei ML
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer.
    Mori JO; Elhussin I; Brennen WN; Graham MK; Lotan TL; Yates CC; De Marzo AM; Denmeade SR; Yegnasubramanian S; Nelson WG; Denis GV; Platz EA; Meeker AK; Heaphy CM
    Nat Rev Urol; 2024 May; 21(5):258-273. PubMed ID: 37907729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy.
    Carpenter V; Saleh T; Min Lee S; Murray G; Reed J; Souers A; Faber AC; Harada H; Gewirtz DA
    Biochem Pharmacol; 2021 Nov; 193():114765. PubMed ID: 34536356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.
    Yang G; Rosen DG; Zhang Z; Bast RC; Mills GB; Colacino JA; Mercado-Uribe I; Liu J
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16472-7. PubMed ID: 17060621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer.
    Xu S; Yang Z; Jin P; Yang X; Li X; Wei X; Wang Y; Long S; Zhang T; Chen G; Sun C; Ma D; Gao Q
    Mol Cancer Ther; 2018 Jun; 17(6):1291-1302. PubMed ID: 29545331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity.
    Malaquin N; Vancayseele A; Gilbert S; Antenor-Habazac L; Olivier MA; Ait Ali Brahem Z; Saad F; Delouya G; Rodier F
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies.
    Liu H; Zhao H; Sun Y
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):769-781. PubMed ID: 34799201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular senescence and the tumour microenvironment.
    Takasugi M; Yoshida Y; Ohtani N
    Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-cancerogenic effects of spontaneous and drug-induced senescence of ovarian cancer cells in vitro and in vivo: a comparative analysis.
    Rutecki S; Szulc P; Pakuła M; Uruski P; Radziemski A; Naumowicz E; Moszyński R; Tykarski A; Mikuła-Pietrasik J; Książek K
    J Ovarian Res; 2022 Jul; 15(1):87. PubMed ID: 35883110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
    Guccini I; Revandkar A; D'Ambrosio M; Colucci M; Pasquini E; Mosole S; Troiani M; Brina D; Sheibani-Tezerji R; Elia AR; Rinaldi A; Pernigoni N; Rüschoff JH; Dettwiler S; De Marzo AM; Antonarakis ES; Borrelli C; Moor AE; Garcia-Escudero R; Alajati A; Attanasio G; Losa M; Moch H; Wild P; Egger G; Alimonti A
    Cancer Cell; 2021 Jan; 39(1):68-82.e9. PubMed ID: 33186519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment and metabolism in prostate cancer.
    Chiarugi P; Paoli P; Cirri P
    Semin Oncol; 2014 Apr; 41(2):267-80. PubMed ID: 24787298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence.
    Liao C; Xiao Y; Liu L
    Cancer Manag Res; 2020; 12():13553-13566. PubMed ID: 33408525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
    Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
    Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer.
    Kallenbach J; Atri Roozbahani G; Heidari Horestani M; Baniahmad A
    Cell Biosci; 2022 Dec; 12(1):200. PubMed ID: 36522745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence.
    Nagesh PKB; Chowdhury P; Hatami E; Kumari S; Kashyap VK; Tripathi MK; Wagh S; Meibohm B; Chauhan SC; Jaggi M; Yallapu MM
    ACS Appl Mater Interfaces; 2019 Oct; 11(42):38537-38554. PubMed ID: 31553876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
    Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
    Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer‑associated fibroblasts under therapy‑induced senescence in the tumor microenvironment (Review).
    Zhang Q; Lou Y; Fang H; Sun S; Jin R; Ji Y; Chen Z
    Exp Ther Med; 2024 Apr; 27(4):150. PubMed ID: 38476922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular senescence in the tumor microenvironment and context-specific cancer treatment strategies.
    Yasuda T; Baba H; Ishimoto T
    FEBS J; 2023 Mar; 290(5):1290-1302. PubMed ID: 34653317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.